RESUMO
Previous studies have demonstrated a stronger seroreactivity against some synthetic peptides responsible for inducing neutralizing antibodies in injecting drug users (IDU) compared to that of individuals sexually infected with HIV-1 (S), but the effectiveness in terms of the neutralizing ability of these antibodies has not been evaluated. Our objective was to study the humoral immune response of IDU by determining the specificity of their antibodies and the presence of neutralizing antibodies. The neutralization capacity against the HIV-1 isolate MN (genotype B), the primary HIV-1 isolate 95BRRJ021 (genotype F), and the seroreactivity with peptides known to induce neutralizing antibodies, from the V2 and V3 loops of different HIV-1 subtypes, were analyzed. Seroreactivity indicates that IDU plasma are more likely to recognize a broader range of peptides than S plasma, with significantly higher titers, especially of V3 peptides. Similar neutralization frequencies of the MN isolate were observed in plasma of the IDU (16/47) and S (20/60) groups in the 1:10 dilution. The neutralization of the 95BRRJ021 isolate was more frequently observed for plasma from the S group (15/23) than from the IDU group (15/47, P = 0.0108). No correlation between neutralization and seroreactivity with the peptides tested was observed. These results suggest that an important factor responsible for the extensive and broad humoral immune response observed in IDU is their infection route. There was very little difference in neutralizing antibody response between the IDU and S groups despite their differences in seroreactivity and health status.
Assuntos
Feminino , Humanos , Masculino , Anticorpos Anti-HIV/imunologia , Antígenos HIV/imunologia , Infecções por HIV/imunologia , HIV-1 , Abuso de Substâncias por Via Intravenosa/imunologia , Reações Cruzadas/imunologia , Genótipo , Infecções por HIV/transmissão , HIV-1 , Testes de Neutralização/métodos , Abuso de Substâncias por Via Intravenosa/complicaçõesRESUMO
Viral hepatitis constitutes a major health issue, with high prevalence among injecting drug users (IDUs). The present study assessed the prevalence and risk determinants for hepatitis B, C and D viruses (HBV, HCV and HDV) infections among 102 IDUs from Rio de Janeiro, Brazil. Serological markers and HCV-RNA were detected by enzyme immunoassay and nested PCR, respectively. HCV genotyping was determined by restriction fragment length polymorphism analysis (RFLP). HBsAg, anti-HBc and anti-HBs were found in 7.8, 55.8 and 24.7 percent of IDUs, respectively. In the final logistic regression, HBV infection was independently associated with male homosexual intercourse within the last 5 years (odds ratio (OR) 3.1; 95 percent confidence interval (CI) 1.1-8.8). No subject presented anti-delta (anti-HD). Anti-HCV was detected in 69.6 percent of subjects, and was found to be independently associated with needle sharing in the last 6 months (OR 3.4; 95 percent CI 1.3-9.2) and with longer duration of iv drug use (OR 3.1; 95 percent CI 1.1-8.7). These data demonstrate that this population is at high risk for both HBV and HCV infection. Among IDUs from Rio de Janeiro, unprotected sexual intercourse seems to be more closely associated with HBV infection, whereas HCV is positively correlated with high risk injecting behavior. Comprehensive public health interventions targeting this population and their sexual partners must be encouraged
Assuntos
Humanos , Feminino , Adulto , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Hepatite D/epidemiologia , Abuso de Substâncias por Via Intravenosa/epidemiologia , Brasil/epidemiologia , Estudos Epidemiológicos , Genótipo , Prevalência , Fatores de Risco , Comportamento Sexual , Fatores SocioeconômicosRESUMO
Hepatitis C virus (HCV) infection is widespread and responsible for more than 60 percent of chronic hepatitis cases. HCV presents a genetic variability which has led to viral classification into at least 6 genotypes and a series of subtypes. These variants present characteristic geographical distribution, but their association with different responses to treatment with interferon and severity of disease still remains controversial. The aim of this study was to investigate the patterns of distribution of HCV genotypes among different exposure categories in Brazil. Two hundred and fifty anti-HCV positive samples were submitted to HCV-RNA detection by RT-PCR and their genotype was determined by restriction fragment length polymorphism (RFLP) analysis. In addition, the genotype/subtype of 60 samples was also determined by a reverse hybridization assay. HCV 1 was the most prevalent (72.0 percent), followed by type 3 (25.3 percent), HCV 2 (2.0 percent) and HCV 4 (0.7 percent). The HCV genotype distribution varied among the different exposure categories, with HCV 1 being more frequent among blood donors, hemophiliacs and hemodialysis patients. A high frequency of HCV 3 was observed in cirrhotic patients, blood donors from the South of Brazil and injecting drug users (IDUs). The general distribution of the HCV genotype in Brazil is similar to that in other regions of the world
Assuntos
Humanos , Hepacivirus/genética , Anticorpos Anti-Hepatite C/sangue , Doadores de Sangue , Brasil , Genótipo , Hepacivirus/classificação , Hepatite C/epidemiologia , Polimorfismo de Fragmento de Restrição , RNA Viral/sangue , Transcrição GênicaRESUMO
Os autores ressaltam a importancia da psiquiatria em uma Clinica de Dor Integrada, apontando as limitacoes do enfoque meramente clinico dos pacientes com dor cronica. Descrevem modelos de psicoterapia utilizados nestes pacientes, que subdividem em: psicoterapia de apoio e psicoterapia de base analitica, preferentemente de duracao breve. Alem disso estao iniciando trabalhos com tecnicas grupais, aplicando tambem o treinamento autogeno de Schultz